Lyra Therapeutics
Price & Volume
Stats
See moreOpen | $3.54 |
Previous Close | $3.61 |
Day Range | $3.54-$3.80 |
52W Range | $2.84-$34 |
Market Cap | $5.9M |
Shares Short | 54,931 |
Financials
See moreRevenue (12 Mos) | $600,000 |
Revenue Growth (YoY) | -87.2% |
Gross Profit (12 Mos) | -$19.7M |
Diluted EPS | -$22.90 |
News
See moreYahoo Finance • 2 months ago
Lyra Therapeutics GAAP EPS of -$3.38 beats by $0.98
Yahoo Finance • 2 months ago
Lyra Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Yahoo Finance • 3 months ago
Lyra Therapeutics Announces Clinical Plan for LYR-210 and Late-Breaking Oral Presentation of Phase 3 ENLIGHTEN 2 Study
Yahoo Finance • 5 months ago
Lyra Therapeutics GAAP EPS of -$5.51, revenue of $0.18M
About
CEO | Dr. Maria Palasis Ph.D. |
CFO | Mr. Jason Cavalier |
Address | 480 Arsenal Way, Watertown, MA, United States, 02472 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 30 |
